PureTech Health (PRTC) Profit After Tax (2024 - 2025)

PureTech Health (PRTC) reported Profit After Tax of -$44.8 million for Q2 2025, up 8.39% on a QoQ basis from -$48.9 million in Q4 2024.

PureTech Health (PRTC) has 2 years of Profit After Tax data on file, last reported at -$44.8 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -2.99 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 30.90 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -14.46 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.03 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 727.20 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -3.63 Mn
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 205.99 Mn
10 PureTech Health 86.36 Mn -190.94 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 -44.78 Mn
Dec 31, 2024 -48.88 Mn